Lynne Padilla Greenblatt

Title: Lynne Padilla Greenblatt: Innovator in CNS Therapeutics

Introduction

Lynne Padilla Greenblatt is a prominent inventor based in Lambertville, NJ (US). She has made significant contributions to the field of pharmacology, particularly in the development of compounds targeting the central nervous system (CNS). With a total of nine patents to her name, her work has had a substantial impact on therapeutic treatments.

Latest Patents

Among her latest patents are the "Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands." This invention provides a compound of formula I and outlines its use for the therapeutic treatment of CNS disorders related to or affected by the 5-HT6 receptor. Another notable patent is for "Pyridinyl-methyl-ethyl cyclohexanecarboxamides as serotonergic agents." This patent describes a compound with 5-HT receptor activity and includes compositions containing such a compound, as well as methods for its use.

Career Highlights

Lynne has worked with notable companies such as Wyeth and American Home Products Corporation. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the pharmaceutical industry.

Collaborations

Throughout her career, Lynne has collaborated with esteemed colleagues, including Michael G Kelly and Yvette L Palmer. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Lynne Padilla Greenblatt is a distinguished inventor whose work in CNS therapeutics has led to significant advancements in the field. Her innovative patents and collaborations highlight her commitment to improving therapeutic options for CNS disorders.